Novel Indices of Coronary Physiology: Do We Need Alternatives to Fractional Flow Reserve?


Journal

Circulation. Cardiovascular interventions
ISSN: 1941-7632
Titre abrégé: Circ Cardiovasc Interv
Pays: United States
ID NLM: 101499602

Informations de publication

Date de publication:
04 2020
Historique:
entrez: 17 4 2020
pubmed: 17 4 2020
medline: 11 11 2020
Statut: ppublish

Résumé

Fractional flow reserve is the current invasive gold standard for assessing the ischemic potential of an angiographically intermediate coronary stenosis. Procedural cost and time, the need for coronary vessel instrumentation, and the need to administer adenosine to achieve maximal hyperemia remain integral components of invasive fractional flow reserve. The number of new alternatives to fractional flow reserve has proliferated over the last ten years using techniques ranging from alternative pressure wire metrics to anatomic simulation via angiography or intravascular imaging. This review article provides a critical description of the currently available or under-development alternatives to fractional flow reserve with a special focus on the available evidence, pros, and cons for each with a view towards their clinical application in the near future for the functional assessment of coronary artery disease.

Identifiants

pubmed: 32295416
doi: 10.1161/CIRCINTERVENTIONS.119.008487
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e008487

Commentaires et corrections

Type : ErratumIn

Auteurs

Giovanni Luigi De Maria (GL)

Heart Centre, John Radcliffe Hospital, Oxford University Hospitals, NHS Foundation Trust, Oxford, United Kingdom (G.L.D.M., R.S., A.P.B.).

Hector M Garcia-Garcia (HM)

MedStar Washington Hospital Centre, Interventional Cardiology Department, Washington, DC (Y.O., H.M.G.-G., A.H.-K., E.S., K.D., R.W.).

Roberto Scarsini (R)

Heart Centre, John Radcliffe Hospital, Oxford University Hospitals, NHS Foundation Trust, Oxford, United Kingdom (G.L.D.M., R.S., A.P.B.).

Alexandre Hideo-Kajita (A)

MedStar Washington Hospital Centre, Interventional Cardiology Department, Washington, DC (Y.O., H.M.G.-G., A.H.-K., E.S., K.D., R.W.).

Nieves Gonzalo López (N)

Interventional Cardiology Department, Hospital Clinico San Carlos, Madrid, Spain (N.G.L.).

Antonio Maria Leone (AM)

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma (A.M.L.).

Giovanna Sarno (G)

Interventional Cardiology Department, Uppsala University, Sweden (G.S.).

Joost Daemen (J)

Interventional Cardiologist at Erasmus University Rotterdam, the Netherlands (J.D.).

Evan Shlofmitz (E)

MedStar Washington Hospital Centre, Interventional Cardiology Department, Washington, DC (Y.O., H.M.G.-G., A.H.-K., E.S., K.D., R.W.).

Allen Jeremias (A)

Cardiac Catheterization Laboratory, St. Francis Hospital, Roslyn, NY (A.J.).

Matteo Tebaldi (M)

Department of Cardiology, University of Ferrara, Italy (M.T.).

Hiram Grando Bezerra (HG)

University Hospitals of Cleveland, OH (G.B.).

Shengxian Tu (S)

Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, China (S.T.).

Pedro A Lemos (PA)

Instituto do Coracao (InCor), Universidade de São Paulo, Brazil (P.A.L.).
Hospital Israelita Albert Einstein, Brazil (P.A.L.).

Yuichi Ozaki (Y)

MedStar Washington Hospital Centre, Interventional Cardiology Department, Washington, DC (Y.O., H.M.G.-G., A.H.-K., E.S., K.D., R.W.).

Kazuhiro Dan (K)

MedStar Washington Hospital Centre, Interventional Cardiology Department, Washington, DC (Y.O., H.M.G.-G., A.H.-K., E.S., K.D., R.W.).

Carlos Collet (C)

Cardiovascular Center Aalst, OLV Clinic, Belgium (C.C.).

Adrian P Banning (AP)

Heart Centre, John Radcliffe Hospital, Oxford University Hospitals, NHS Foundation Trust, Oxford, United Kingdom (G.L.D.M., R.S., A.P.B.).

Emanuele Barbato (E)

Department of Advanced Biomedical Sciences, University of Naples Federico II, Italy (E.B.).

Nils P Johnson (NP)

McGovern Medical School at UTHealth and Memorial Hermann Hospital, Houston, TX (N.P.J.).

Ron Waksman (R)

MedStar Washington Hospital Centre, Interventional Cardiology Department, Washington, DC (Y.O., H.M.G.-G., A.H.-K., E.S., K.D., R.W.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH